ReviewMolecules (Basel, Switzerland)2014

Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.

Gaëlle Mariaule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.